TECHNOLOGY, SCIENCE AND CREATIVITY DEVOTED TO CUSTOMER SERVICE

Similar documents
peace of mind For from development to commercial supply

Section heading. Strapline sub-heading

Leader in Pharmaceutical Films

API hapis High Potency Active Pharmaceutical Ingredients. High Potency Active Pharmaceutical Ingredients. Innovation made. Easy.

Glatt Technology Center

TRIPS and Access to Medicines. WR Briefing

Glatt Technology Center

Quality by Design, Clinical Relevance & Lifecycle Considerations

Pharmaceutical Manufacturing and Engineering Catalog Excerpt

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Pharmaceutical Process Development

JUST SCRATCHING THE SERVICE

MEDIA RELEASE FOR IMMEDIATE RELEASE 4 JUNE 2014

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background

THE AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION RECOMMENDATIONS REGARDING QUALIFICATIONS FOR

Find and analyse the most relevant patents for your research

Globalisation increasingly affects how companies in OECD countries

WHO WE ARE MISSION STATEMENT

UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

Challenges of Implementation of ICH Q 8

Brazilian industry s activities for international convergence. Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma

Pharmaceutical Products and Services

Dynamics of National Systems of Innovation in Developing Countries and Transition Economies. Jean-Luc Bernard UNIDO Representative in Iran

Intellectual property governance and strategic value creation:

HIV and co-infection medicines

Oil & Gas. GST Engineering

University joins Industry: IP Department. Georgina Marjanet Ferrer International, SA

Industry Expertise: P R O D U C E R S P R O D U C E R S Bursting With Flavors Since 1981 Bursting Flavors

GSK s Development of Novel Oral Delivery Technologies Perspectives


Implementing Quality Systems

WHITE PAPER FACILITY FOCUS: GMP Facility Modernization. By: David M. Marks, P.E.

New York Bar admission (or eligibility to obtain admission promptly) is required.

ICH Q8 / ICH Q11 Training Course

Bosch Packaging Academy Seminars & Workshops

Vetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018

VACCINE MANUFACTURING IN DEVELOPING COUNTRIES

Science Integration Fellowship: California Ocean Science Trust & Humboldt State University

Emerging Sources Citation Index. More research and trends from emerging and less-established sources. Romania Case Study

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Media & Entertainment. Shaping tomorrow with you

Research Patents in Biotech SMEs

Purpose of the summary

UNIVERSITIES AND TECHNOLOGY TRANSFER PATENT ATTORNEYS TRADE MARK ATTORNEYS

Intellectual Property

Study of Comparative Advantages of Chinese and Indian Pharmaceutical Industries under Globalization

SCIENTIFIC INTEGRITY

PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS)

Intelligent Textiles Limited. John Hopkins October 2012

LIGHTHOUSE. The Science of Pharmaceutical Manufacturing

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment

The Sherwin-Williams Company

What could be driving the Lab of the future and is the Smart Lab really a thing?

Making lives better every day. This is UCB

Training. Education CALENDAR FEDEGARI TECH CENTERS DM#407036

HARNESSING TECHNOLOGY

Overview on Medicines Regulation: regulatory cooperation and harmonization in focus

Intellectual Property

Presentation. March 2007

The Transition to Model-Based Drug Development. Phase 1: Formalizing the Pharmacometric Process

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei

SCIENCE + BEAUTY. Technical Expertise for the Beauty Industry. 6 pages total

Table Of Content. Stichting Health Action International... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...

ADVANCING KNOWLEDGE. FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020

INTELLECTUAL PROPERTY STRATEGIC CONSULTING

FOCUSED INNOVATIONS IN LIFE SCIENCES

Midwest Regional Forum. Work Smarter Not Harder Leveraging Prior Knowledge to Accelerate CMC Programs

Appendix 2 Statoil: About our brand. 14 pages

1. Protecting the work and expressing the potential of our clients' companies

ACCELERATING THE FUTURE OF SEMICONDUCTORS

CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals

Intellectual Property Policy. DNDi POLICIES

(Fig.) JPMA Industry Vision 2025

With you from pit to port. Mining & Metallurgy

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

CORPORATE OVERVIEW BREAKING THERMAL BARRIERS

Draft Plan of Action Chair's Text Status 3 May 2008

Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter

Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO

Intellectual Property, Vaccine Production and Technology Transfer

Intellectual Property Management Medicines for Malaria Venture. Life Sciences Symposium WIPO 15 December 2008

THIS IS RESEARCH. THIS IS AUBURN RESEARCH.

THE DRIVING FORCE BEHIND THE FOURTH INDUSTRIAL REVOLUTION

Connecting Science and Society. NWO strategy

MENTORS REGULATORY AFFAIRS. Christophe AMIEL Head of Medical Device & Digital, Voisin Consulting Life Sciences STRATEGY/BUSINESS

Facing the Future: Additive Manufacturing SECOND ROUND. Call for Partners: Consortium Study. Our partners:

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Engr. VIRGINIA F. AUMENTADO Patent Information Analytics and Technology Monitoring Division (PATMD)

Symposium on Continuous Manufacturing of Pharmaceuticals Notes

NATIONAL DESIGN POLICY. Approved by Government of India

Be prepared! Upgrade for mission success.

Lupin Limited Annual Results FY12. Investor Presentation May being

CHEMISTRY AND PHARMACEUTICALS PATENT ATTORNEYS TRADE MARK ATTORNEYS

FROM THE GLASS TUBE TO OPTIMUM SYSTEM PACKAGING

Supporting Industrial Property for Shared Prosperity. The Japan Funds-in-Trust for Industrial Property in Asia and the Pacific

COURSE 2. Mechanical Engineering at MIT

MITHRA PHARMACEUTICALS ANNOUNCES ITS FIRST HALF 2016 FINANCIAL RESULTS AND OPERATIONAL PROGRESS

SMART HYDRAULICS MINING & CONSTRUCTION AGRICULTURE & MAINTENANCE LOAD HANDLING FORESTRY HOISTING RECYCLING DEFENSE INDUSTRIAL ENERGY

AAL2BUSINESS Towards successful commercialization of AAL solutions

Transcription:

TECHNOLOGY, SCIENCE AND CREATIVITY DEVOTED TO CUSTOMER SERVICE

Who we are Our experience, your support. We are one of the leading companies specialized in research, development and manufacturing of pharmaceutical products for third parties. We have a history of over 35 years offering effective solutions to our customers through science, technology and a team of highly trained professionals. Novocap INNOVATION EXPERIENCE SERVICE HUMAN QUALITY We started our activities in Buenos Aires, Argentina in 1973 as Diffucap Eurand S.A. and since our establishment we have specialized in the development and manufacturing of value-added pharmaceutical products enabled by the use of oral modified-release technologies. Besides technology, what makes us special is our people. All of our projects are handled by collaborative teams integrated by experienced professionals driven by a shared vision and a culture of customer service.

What we do Our services, your solution. We serve our customers. We collaborate throughout all the stages of development, from the idea to the finished product, including formulation development, clinical research and industrial-scale production under GMP standards. We offer our experience and ability to solve the most complex challenges. Comprehensive service DEVELOPMENT RESEARCH PRODUCTION Development: Our technologies allow us to create high value-added pharmaceutical products: Extended Release Increased Solubility / Absorption Taste Masking Enteric / Colonic Release Combination of Incompatible / Unstable Drugs Clinical Research: We specialize in pharmacokinetic studies. We have broad experience in comparative bioavailability and bioequivalence studies. Production: We have a unique industrial plant in Latin America. We manufacture over 300 million doses (capsules, tablets, microcapsules and pellets) per year.

We innovate Our innovation, your competitive advantage. We form interdisciplinary teams, which combine technology, science and creativity, integrating specialized know-how and the ability to transform ideas into effective solutions. TECHNOLOGY SCIENCE CREATIVITY QUALITY Quality Assurance Qualifications Validations Quality Control INDUSTRIAL PLANT Production Health and Safety Engineering REGULATORY AFFAIRS Registration DEVELOPMENT Pharmaceutical Analytical TEAM CUSTOMER SERVICE Business Development Customer Management INTELLECTUAL PROPERTY Trademarks Patents CLINICAL STUDIES Bioavailability Bioequivalence

We are chosen Working together with our customers, we create high value-added products. We work openly and in close collaboration with our customers in order to create products with significant advantages, which add value to your business. We build long lasting relationships based on trust, professionalism and accountability. Using our technology, we have developed over 100 products, which are marketed by our customers worldwide. STRENGTH PROFESSIONALISM TRUST ACCOUNTABILITY

We move forward Building the future together. We are at the forefront of technology. Our mission is to provide reliable solutions and tailored to the needs of our customers, today and tomorrow. The innovative culture and work environment in Novocap motivates us to continue learning and developing new skills. In order to enhance our knowledge and generate new solutions, we actively look for alliances with other pharmaceutical companies, universities and research centers. Trust us. Let us show you that we are the strategic partner your business needs. Yesterday Regular tablets and capsules. Today Modified release microgranules. Taste-masked microcapsules. Formulations of increased solubility. Formulations of incompatible active principles. Tomorrow Increased oral absorption of low-permeability molecules. Alternative routes of administration of biotech products.

w w w.novoc ap.com Novocap S.A. Industrial Plant: Administration: Tel (54-11) 4208-2975 Ing. Torcuato Di Tella 968 Ing. Torcuato Di Tella 911 info@novocap.com (B1868BIB) Avellaneda (B1868BIA) Avellaneda www.novocap.com Buenos Aires, Argentina Buenos Aires, Argentina